Macquarie Group
NVAX icon

Macquarie Group’s Novavax NVAX Stock Holding History

Macquarie Group’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2
Closed -$25 – 1833
2024
Q2 		$25 Sell
2
-7
-78% -$70 ﹤0.01% 1884
2024
Q1 		$0 Buy
+9
New +$42 ﹤0.01% 1934
2022
Q3 		– Sell
-881
Closed -$38.2K – 2263
2022
Q2 		$45K Sell
881
-238
-21% -$12.3K ﹤0.01% 2079
2022
Q1 		$82 Sell
1,119
-133
-11% -$11.9K ﹤0.01% 2015
2021
Q4 		$179K Sell
1,252
-19,700
-94% -$3.38M ﹤0.01% 1786
2021
Q3 		$4.34M Buy
20,952
+20,283
+3,032% +$4.47M ﹤0.01% 1144
2021
Q2 		$142K Sell
669
-1,283
-66% -$235K ﹤0.01% 1868
2021
Q1 		$354K Sell
1,952
-176
-8% -$35.1K ﹤0.01% 1587
2020
Q4 		$237K Sell
2,128
-4,142
-66% -$440K ﹤0.01% 1619
2020
Q3 		$680K Buy
6,270
+4,142
+195% +$505K ﹤0.01% 1333
2020
Q2 		$177K Buy
+2,128
New +$81.4K ﹤0.01% 1584
2016
Q3 		– Sell
-28,000
Closed -$4.07M – 1569
2016
Q2 		$4.07M Sell
28,000
-3,007
-10% -$345K ﹤0.01% 936
2016
Q1 		$3.2M Buy
31,007
+20,453
+194% +$2.19M 0.01% 823
2015
Q4 		$1.77M Buy
10,554
+136
+1% +$20.9K ﹤0.01% 963
2015
Q3 		$1.47M Buy
10,418
+1,271
+14% +$285K ﹤0.01% 1053
2015
Q2 		$2.04M Buy
9,147
+1,419
+18% +$249K ﹤0.01% 1021
2015
Q1 		$1.28M Buy
+7,728
New +$1.25M ﹤0.01% 1098

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Macquarie Group's NVAX Position: Q3 2024 in Review

Macquarie Group sold out of Novavax (NVAX) in Q3 2024, closing a stake of 2 shares — an estimated $25 sold.

Macquarie Group first reported a position in NVAX in Q1 2015 and held it in 17 quarters. The position peaked at $4.34M in Q3 2021. 237 funds tracked by Wall St. Rank hold NVAX as of Q3 2024.

  • Macquarie Group reported no remaining Novavax position as of Q3 2024 after selling out during the quarter.
  • Macquarie Group sold 2 Novavax shares in Q3 2024, an estimated $25.
  • Macquarie Group first reported a position in Novavax in Q1 2015 and held it in 17 quarters.
  • Macquarie Group's Novavax position peaked at $4.34M in Q3 2021.
  • 237 funds tracked by Wall St. Rank held Novavax as of Q3 2024.

Based on Macquarie Group's 13F filing for Q3 2024, filed 14 Nov 2024.